Therapeutic use of anti-CS1 antibodies

Details for Australian Patent Application No. 2012216291 (hide)

Owner Abbott Biotherapeutics Corp.

Inventors Powers, David B.; Liu, Gao; Williams, Marna; Landolfi, Nicolas F.; Tso, Yun J.

Agent Davies Collison Cave

Pub. Number AU-A-2012216291

Parent 2010214661

Filing date 17 August 2012

Wipo publication date 6 September 2012

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

30 August 2012 Complete Application Filed

6 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216291

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216292-Method and device for determining a location of a communications device

2012216290-Server for medical device